Abstract
AIM: To evaluate the therapeutic effects of Dachengqi decoction as an adjutant therapy on recurrent acute pancreatitis.
METHODS: Fifty patients with recurrent acute pancreatitis were randomly divided into control group (n = 25) and treatment group (n = 25). Control group received routine comprehensive treatment only while treatment group received additional Dachengqi decoction as an adjutant therapy. Clinical manifestations such as the acute physiology and chronic health evaluationⅡ(APACHEⅡ) score, serum amylase, abdominal pain on day 1, 3, 5 were assessed and analyzed in addition to duration of fasting and hospitalization, incidence of complications and recurrence rate of 1-year follow-up.
RESULTS: Compared with the control group, (APACHEⅡ) score on day 3 (6.03 ± 0.36 vs 9.07 ± 0.52, P < 0.05) and leukocyte count (10.37 ± 1.22 × 109vs 14.91 ± 1.41 × 109, P < 0.05), serum amylase (57 ± 19 vs 101 ± 22, P < 0.05) on day 5 were significantly decreased; the time of fasting (6.1 ± 1.1 vs 10.4 ± 1.5, P < 0.05), abdominal pain (3.3 ± 1.2 vs 5.4 ± 1.4, P < 0.05), abdominal distention (4.2 ± 2.5 vs 7.1 ± 2.2, P < 0.05) and duration of hospitalization (11.6 ± 3.3 vs 19.7 ± 4.2, P < 0.05), the incidence of complications (12% vs 24%, P < 0.05) and relapse rate of one-year follow-up (24% vs 52%, P < 0.05) were significantly reduced in treatment group.
CONCLUSION: Dachengqi decoction has some accessory effect for the patients with recurrent acute pancreatitis.
Collapse